A NEW SCORING SYSTEM FOR PREDICTION OF PDA
- Conditions
- Patent Ductus ArteriosusPrematurity; Extreme
- Registration Number
- NCT04270240
- Brief Summary
Patent ductus arteriosus (PDA) is an important morbidity of that the diagnosis and treatment is controversy in premature infants. A number of scoring systems have been developed, including the findings of echocardiography on the diagnosis and treatment of PDA. This study aimed to develop a new clinical scoring system that will enable the rapid, standard and noninvasive evaluation of hemodynamically significant PDA earlier, without relying on echocardiographic findings in premature babies with extremely low birth weight, and to determine the role of this scoring system in early diagnosis and treatment.
- Detailed Description
This study aimed to develop a new clinical scoring system that will enable the rapid, standard and noninvasive evaluation of hemodynamically significant PDA earlier, without relying on echocardiographic findings in premature babies with extremely low birth weight, and to determine the role of this scoring system in early diagnosis and treatment.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
- informed consent obtained from parents
- extremely preterm infants
- infants born before 28 gestational week
- lack of informed consent
- chromosomal abnormality
- cardiovascular abnormality
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of Participants with Patent Ductus Arteriosus 7 days number of participants who diagnosed for hemodynamically significant PDA and had an elevated score of the newly developed system by us.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Seda Yilmaz Semerci
🇹🇷Istanbul, Turkey